Skip to content

Low dose aspirin

DRUG9 trials

Sponsors

Mount Sinai Hospital, Canada, Dr.Vandana Bansal, NICHD Global Network for Women's and Children's Health, Assiut University, Shanghai First Maternity and Infant Hospital

Conditions

Antiphospholipid Antibody SyndromeEclampsia PreeclampsiaFetal Growth RetardationFoetal Growth RestrictionIntrauterine Growth RestrictionPlacenta DiseasesPre-EclampsiaPregnancy and Childbirth Intrauterine growth restriction

Phase 2

Phase 3

Phase 4

Unknown Phase

Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
TerminatedNCT00564174
Mount Sinai Hospital, CanadaAntiphospholipid Antibody Syndrome, Recurrent Pregnancy Loss
Start: 2000-03-31End: 2005-09-30Updated: 2007-11-27
Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)
CompletedNCT02409680
NICHD Global Network for Women's and Children's HealthPremature Birth
Start: 2016-03-23End: 2019-04-11Updated: 2024-11-21
Sildenafil citrate for the treatment of asymmetrical intrauterine growth restriction: A randomized controlled trial
RecruitingPACTR201705002278236
Ain Shams universityPregnancy and Childbirth Intrauterine growth restriction
Start: 2017-05-02Target: 80Updated: 2026-09-14
Effect of early administration of low dose aspirin therapy in obese pregnant women on miscarriage rate and uterine artery Doppler indices .
Active, not recruitingPACTR201710002653297
CUHPregnancy and Childbirth Obstetrics
Start: 2017-10-01Target: 400Updated: 2026-09-14
Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women
NCT03365466
Shanghai First Maternity and Infant HospitalRecurrent Implantation Failure
Start: 2017-12-31End: 2019-02-28Target: 200Updated: 2017-12-07
Long-term follow-up of children exposed in utero to low-dose aspirin for prevention of preterm birth, a follow-up of the APRIL trial
RecruitingNL-OMON21183
Amsterdam UMCPrevention of preterm birth in multiple pregnancy
Start: 2020-07-01Target: 200Updated: 2024-02-28

Related Papers